• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组假结核耶尔森氏菌L-天冬酰胺酶的产生菌构建、表达优化及纯化

Creation of a producent, optimization of expression, and purification of recombinant Yersinia pseudotuberculosis L-asparaginase.

作者信息

Sidoruk K V, Pokrovsky V S, Borisova A A, Omeljanuk N M, Aleksandrova S S, Pokrovskaya M V, Gladilina Ju A, Bogush V G, Sokolov N N

机构信息

Institute of Genetics; Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia.

出版信息

Bull Exp Biol Med. 2011 Dec;152(2):219-23. doi: 10.1007/s10517-011-1493-7.

DOI:10.1007/s10517-011-1493-7
PMID:22808465
Abstract

Recombinant E. coli strain producing Y. pseudotuberculosis Q66CJ2 (YpA) L-asparaginase II was created. Gene ansB homologue encoding Y. pseudotuberculosis IP 32953 L-asparaginase precursor was synthesized. The gene was cloned in pBad24 expression vector and expressed in E. coli BL21 (DE3) strain. Optimal conditions for the producer strain culturing were selected. An effective method for isolation and purification of the enzyme by two-staged column chromatography was developed.

摘要

构建了产生假结核耶尔森菌Q66CJ2(YpA)L-天冬酰胺酶II的重组大肠杆菌菌株。合成了编码假结核耶尔森菌IP 32953 L-天冬酰胺酶前体的ansB同源基因。该基因被克隆到pBad24表达载体中,并在大肠杆菌BL21(DE3)菌株中表达。选择了生产菌株培养的最佳条件。开发了一种通过两步柱色谱法分离和纯化该酶的有效方法。

相似文献

1
Creation of a producent, optimization of expression, and purification of recombinant Yersinia pseudotuberculosis L-asparaginase.重组假结核耶尔森氏菌L-天冬酰胺酶的产生菌构建、表达优化及纯化
Bull Exp Biol Med. 2011 Dec;152(2):219-23. doi: 10.1007/s10517-011-1493-7.
2
Cloning, expression and characterization of the recombinant Yersinia pseudotuberculosis L-asparaginase.重组耶尔森氏假结核菌L-天冬酰胺酶的克隆、表达及特性分析
Protein Expr Purif. 2012 Mar;82(1):150-4. doi: 10.1016/j.pep.2011.12.005. Epub 2011 Dec 29.
3
Expression and purification of L-asparaginase from Escherichia coli and the inhibitory effects of cyclic dipeptides.大肠杆菌L-天冬酰胺酶的表达、纯化及环二肽的抑制作用
Nat Prod Res. 2017 Sep;31(18):2099-2106. doi: 10.1080/14786419.2016.1277350. Epub 2017 Jan 20.
4
A Newly Identified Glutaminase-Free ʟ-Asparaginase (ʟ-ASPG86) from the Marine Bacterium Mesoflavibacter zeaxanthinifaciens.一种新鉴定出的来自海洋细菌玉米黄质黄素微杆菌的无谷氨酰胺酶L-天冬酰胺酶(L-ASPG86)。
J Microbiol Biotechnol. 2016 Jun 28;26(6):1115-23. doi: 10.4014/jmb.1510.10092.
5
[Physicochemical properties and antiproliferative activity of recombinant Yersinia pseudotuberculosis L-asparaginase].重组假结核耶尔森氏菌L-天冬酰胺酶的理化性质及抗增殖活性
Prikl Biokhim Mikrobiol. 2013 Jan-Feb;49(1):24-8. doi: 10.7868/s0555109913010169.
6
[Cross-immunogenicity of various bacterial L-asparaginases].[各种细菌L-天冬酰胺酶的交叉免疫原性]
Zh Mikrobiol Epidemiol Immunobiol. 2014 Nov-Dec(6):100-4.
7
[Antitumor activity of L-asparaginase from Yersinia pseudotuberculosis].[假结核耶尔森菌L-天冬酰胺酶的抗肿瘤活性]
Biomed Khim. 2008 Nov-Dec;54(6):712-9.
8
Construction of expression systems for Escherichia coli asparaginase II and two-step purification of the recombinant enzyme from periplasmic extracts.大肠杆菌天冬酰胺酶II表达系统的构建及从周质提取物中对重组酶的两步纯化
Protein Expr Purif. 1991 Apr-Jun;2(2-3):144-50. doi: 10.1016/1046-5928(91)90063-o.
9
[Purification and properties of recombinant Erwinia carotovora L-asparaginase expressed in E.coli cells].[在大肠杆菌细胞中表达的重组胡萝卜软腐欧文氏菌L-天冬酰胺酶的纯化及性质]
Biomed Khim. 2003 Sep-Oct;49(5):502-7.
10
Extracellular expression and single step purification of recombinant Escherichia coli L-asparaginase II.重组大肠杆菌L-天冬酰胺酶II的胞外表达及一步纯化
Protein Expr Purif. 2004 Nov;38(1):29-36. doi: 10.1016/j.pep.2004.07.009.

引用本文的文献

1
Predictive markers for efficiency of the amino-acid deprivation therapies in cancer.癌症中氨基酸剥夺疗法疗效的预测标志物。
Front Med (Lausanne). 2022 Nov 3;9:1035356. doi: 10.3389/fmed.2022.1035356. eCollection 2022.
2
Molecular Analysis of L-Asparaginases for Clarification of the Mechanism of Action and Optimization of Pharmacological Functions.L-天冬酰胺酶的分子分析:作用机制的阐明及药理功能的优化
Pharmaceutics. 2022 Mar 9;14(3):599. doi: 10.3390/pharmaceutics14030599.
3
L-Lysine α-Oxidase: Enzyme with Anticancer Properties.
L-赖氨酸α-氧化酶:具有抗癌特性的酶。
Pharmaceuticals (Basel). 2021 Oct 22;14(11):1070. doi: 10.3390/ph14111070.
4
Plasma pharmacokinetics and tissue distribution of L-lysine α-oxidase from Trichoderma cf. aureoviride RIFAI VKM F- 4268D in mice.米曲霉 RIFAI VKM F-4268D 来源的 L-赖氨酸 α-氧化酶在小鼠体内的药代动力学和组织分布。
Amino Acids. 2021 Jan;53(1):111-118. doi: 10.1007/s00726-020-02930-4. Epub 2021 Jan 4.
5
Development of Processes for Recombinant L-Asparaginase II Production by Bl21 (De3): From Shaker to Bioreactors.利用BL21(DE3)生产重组L-天冬酰胺酶II的工艺开发:从摇瓶到生物反应器
Pharmaceutics. 2020 Dec 24;13(1):14. doi: 10.3390/pharmaceutics13010014.
6
Penetration into Cancer Cells via Clathrin-Dependent Mechanism Allows L-Asparaginase from to Inhibit Telomerase.通过网格蛋白依赖机制穿透癌细胞可使来自[具体来源未给出]的L-天冬酰胺酶抑制端粒酶。
Pharmaceuticals (Basel). 2020 Sep 30;13(10):286. doi: 10.3390/ph13100286.
7
Methionine gamma lyase from Clostridium sporogenes increases the anticancer effect of doxorubicin in A549 cells and human cancer xenografts.产芽孢梭菌蛋氨酸γ裂解酶增强阿霉素在 A549 细胞和人源异种移植瘤中的抗癌作用。
Invest New Drugs. 2019 Apr;37(2):201-209. doi: 10.1007/s10637-018-0619-4. Epub 2018 Jun 15.